Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States
Open Access
- 1 November 2014
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (11) , 6484-6489
Abstract
Ongoing surveillance for Streptococcus pneumoniae is needed to assess the impact of the pneumococcal conjugate vaccine introduced in 2010 (PCV13). Forty-two U.S. centers submitted S. pneumoniae isolates between 1 October 2012 and 31 March 2013. Susceptibility testing was performed by use of a broth dilution method as recommended by the Clinical and Laboratory Standards Institute. Serotyping was performed by multiplex PCR and the Quellung reaction. Multidrug resistance (MDR) was defined as nonsusceptibility to penicillin (PNSP; MIC ≥ 0.12 μg/ml) combined with resistance to ≥2 non-β-lactam antimicrobials. Penicillin-resistant S. pneumoniae (PRSP) was defined as a penicillin MIC of ≥2 μg/ml. For the 1,498 isolates collected during 2012-13, the PRSP and MDR rates were 14.2 and 21.0%, respectively. These percentages were lower than rates obtained in a surveillance study conducted 4 years earlier in 2008-09 (17.0 and 26.6%, respectively). The most common serotypes identified in 2012-13 were 3, 35B, and 19A, each representing 9 to 10% of all isolates. The largest percentage of PNSP in 2012-13 were found in serotypes 35B (24.8%), 19A (23.5%), and 15A (10.3%). Predominant PRSP serotypes were 19A (54.5%), 35B (28.2%), and 19F (7.0%). Major MDR serotypes were 19A (38.5%), 15A (16.9%), 6C (8.3%), and 35B (6.4%). The change in prevalence of PCV13 serotypes (43.4 to 27.1%) was primarily due to a decrease in serotype 19A strains, i.e., 22% of all strains in 2008-09 to 10% of all strains in 2012-13. Among the PNSP subset, serotypes showing a proportional increase were 35B, 15B, and 23B. Among MDR strains, the largest proportional increases were observed in serotypes 35B, 15B, and 23A.Keywords
This publication has 16 references indexed in Scilit:
- Serotype 35B Streptococcus pneumoniae, Japan, 2002–2012Journal of Infection and Chemotherapy, 2014
- Bacterial Meningitis in the United States, 1998–2007New England Journal of Medicine, 2011
- Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐AnalysisClinical Infectious Diseases, 2010
- Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Association of Serotypes of Streptococcus pneumoniae with Age in Invasive Pneumococcal DiseaseJournal of Clinical Microbiology, 2010
- Effect of Pneumococcal Conjugate Vaccine on Pneumococcal MeningitisNew England Journal of Medicine, 2009
- Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniaeNew England Journal of Medicine, 2006
- Sequential Multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae IsolatesJournal of Clinical Microbiology, 2006
- Emergence of a Novel Penicillin‐Nonsusceptible, Invasive Serotype 35B Clone ofStreptococcus pneumoniaewithin the United StatesThe Journal of Infectious Diseases, 2002
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000